347 related articles for article (PubMed ID: 9513037)
1. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
2. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
4. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
[TBL] [Abstract][Full Text] [Related]
5. [Contrast agent improves diagnostic value of dobutamine stress echocardiography].
Uehara H; Yamamoto T; Hirano Y; Ozasa Y; Yamada S; Ikawa H; Ishikawa K
J Cardiol; 2001 Mar; 37(3):135-41. PubMed ID: 11281053
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
[TBL] [Abstract][Full Text] [Related]
7. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
10. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure.
Zotz RJ; Genth S; Mitrovic V; Waaler A; Erbel R; Meyer J
Eur Heart J; 1996 Feb; 17(2):302-7. PubMed ID: 8732386
[TBL] [Abstract][Full Text] [Related]
11. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
Voci P; Bilotta F; Merialdo P; Agati L
J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
[TBL] [Abstract][Full Text] [Related]
12. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
Keller MW; Glasheen W; Kaul S
J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
[TBL] [Abstract][Full Text] [Related]
13. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
[TBL] [Abstract][Full Text] [Related]
14. Assessing myocardial perfusion with Albunex during coronary artery bypass surgery: technical considerations and safety of aortic root injections.
Aronson S; Savage R; Fernandez A; Klein A; Young C; Toledano A; Lee BK; Karp RB; Lytle B; Loop F
J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):713-8. PubMed ID: 8910149
[TBL] [Abstract][Full Text] [Related]
15. Contrast echocardiography 1996. A review.
Villarraga HR; Foley DA; Mulvagh SL
Tex Heart Inst J; 1996; 23(2):90-7. PubMed ID: 8792539
[TBL] [Abstract][Full Text] [Related]
16. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
18. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
19. Potential pitfalls of visualization of myocardial perfusion by myocardial contrast echocardiography with harmonic gray scale B-mode and power Doppler imaging.
Masugata H; Yukiiri K; Takagi Y; Ohmori K; Mizushige K; Kohno M
Int J Cardiovasc Imaging; 2004 Apr; 20(2):117-25. PubMed ID: 15068143
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary and aortic root myocardial contrast echocardiography: the effect of route, dose, and pharmacologic coronary vasodilation.
Bach DS; Armstrong WF; Collins T; Muller DW; Ramee SR; Bruns DE; Cheirif J
J Am Soc Echocardiogr; 1995; 8(5 Pt 1):719-27. PubMed ID: 9417216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
